Avricore Health (AVCRF) Debt to Equity (2014 - 2023)

Avricore Health has disclosed Debt to Equity across 5 years of filings, most recently posting $0.02 for Q4 2023.

• In Q4 2023, Debt to Equity fell 51.12% year-over-year to $0.02; the TTM figure through Dec 2023 stood at $0.02 (down 51.12% YoY), while the FY2023 annual figure was $0.02, down 51.12% from the prior year.
• Debt to Equity fell to $0.02 in Q4 2023, from $0.02 in the prior quarter.
• Over the last five years, Debt to Equity for AVCRF reached as high as $0.04 in Q4 2022 and fell as low as -$1.38 in Q4 2020.
• The 4-year median for Debt to Equity is $0.02 (2023), against an average of -$0.35.
• Annual changes were most pronounced in 2022 — Debt to Equity surged 123.71% — and 2023, when it plunged 51.12%.
• A 4-year view of Debt to Equity shows it stood at -$1.38 in 2020, then jumped by 101.32% to $0.02 in 2021, then surged by 123.71% to $0.04 in 2022, then sank by 51.12% to $0.02 in 2023.
• According to Business Quant data, Debt to Equity over the past three periods registered $0.02, $0.02, and $0.02 for Q4 2023, Q3 2023, and Q2 2023 respectively.